XML 140 R108.htm IDEA: XBRL DOCUMENT v3.20.4
Related Party Transactions - Additional Information (Details)
1 Months Ended 10 Months Ended 12 Months Ended
Jan. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Oct. 31, 2019
USD ($)
Jan. 31, 2018
shares
Jul. 31, 2018
shares
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2018
USD ($)
relatedParty
shares
Oct. 31, 2017
USD ($)
Related Party Transaction [Line Items]                  
Shares issued as payment for services             $ 10,446,000 $ 10,695,000  
Shares issued during the period (in shares) | shares       6,900,000          
Dividend income from investments in preferred stock           $ 0 48,000 14,841,000  
Proceeds from sales of equity securities     $ 21,587,000     0 23,456,000 217,000  
Receivables   $ 2,030,000       232,000 2,030,000    
Third Security                  
Related Party Transaction [Line Items]                  
Expense for services           159,000 $ 26,000 $ 47,000  
Common stock calculation period             30 days    
Shares issued as payment for services, shares | shares             1,606,062 696,033  
Shares issued as payment for services             $ 8,233,000 $ 8,324,000  
Sublease rental income           $ 83,000 89,000    
Sublease rental income               89,000  
Affiliates of Third Security                  
Related Party Transaction [Line Items]                  
Shares issued during the period (in shares) | shares       1,000,000          
Castle Creek Biosciences, Inc.                  
Related Party Transaction [Line Items]                  
Proceeds from sales of equity securities   1,280,000              
Proceeds from Convertible Preferred Shares and convertible note $ 3,311,000                
Receivables   $ 3,311,000         3,311,000    
Changes in fair value, gain             3,222,000    
Common Stock | Third Security                  
Related Party Transaction [Line Items]                  
Expense for services             $ 800,000    
Series A Preferred Shares                  
Related Party Transaction [Line Items]                  
Shares issued during the period (in shares) | shares         0        
Series A Preferred Shares | Affiliates of Third Security                  
Related Party Transaction [Line Items]                  
Convertible preferred stock, amount authorized                 $ 100,000,000
Third Security | Executive Chairman                  
Related Party Transaction [Line Items]                  
Ownership interest           100.00%      
ZIOPHARM Oncology, Inc.                  
Related Party Transaction [Line Items]                  
Dividend income from investments in preferred stock               $ 14,793,000  
Collaboration and licensing agreements | Various ECC Agreements                  
Related Party Transaction [Line Items]                  
Number of related parties with terminated agreements | relatedParty               3  
Revenue recognized from previously deferred balances               $ 11,877,000